Syneos Health Launches Ventilator Initiative to Raise Awareness of Bridging Option to Address Ventilator Shortage for COVID-19 Patients - Seite 3

About Informa Pharma Intelligence
Informa Pharma Intelligence powers a full suite of analysis products — Datamonitor Healthcare, Sitetrove, Trialtrove, Pharmaprojects, Medtrack, Biomedtracker, Scrip, Pink Sheet and In Vivo — to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth.

Skipta, part of Informa’s Pharma Intelligence vertical, is the leading social network of specialized online medical communities for verified healthcare professionals (HCPs). Skipta’s growing network of more than 25 specialty communities allow verified HCPs to communicate and collaborate with peers in a focused, secure environment. The company enables pharmaceutical and biotech brands to drive awareness and behavior change by bringing to them multi-channel access to 700,000+ verified HCPs through integrated engagement programs.

With more than 500 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&D project isn’t covered through the breadth and depth of data available to customers. For more information, visit pharmaintelligence.informa.com.

Contact:

Syneos Health
Investor Relations Contact:
Ronnie Speight
Senior Vice President, Investor Relations
[phone]
[e-mail]

Press/Media Contact:
Danielle DeForge
Executive Director, External Communications
[phone]
[e-mail]

Informa Pharma Intelligence
Katleen Richardson
Chief Marketing Officer
[e-mail]

_______________
ⁱ U.S. Food and Drug Administration. Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 19 (COVID-19) Public Health Emergency. Guidance for Industry and Food and Drug Administration Staff. March 2020. https://www.fda.gov/regulatory-information/search-fda-guidance-documen ...